VENATOR MATERIALS PLC (VNTR)

GB00BF3ZNS54 - Common Stock

0.2687  -0.02 (-7.66%)

After market: 0.2783 +0.01 (+3.57%)

Fundamental Rating

1

VNTR gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 84 industry peers in the Chemicals industry. Both the profitability and financial health of VNTR have multiple concerns. VNTR has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year VNTR has reported negative net income.
VNTR had a negative operating cash flow in the past year.
In the past 5 years VNTR always reported negative net income.
VNTR had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

The profitability ratios for VNTR are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 3.91%, VNTR is doing worse than 86.81% of the companies in the same industry.
VNTR's Gross Margin has declined in the last couple of years.
VNTR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 3.91%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-29.52%
GM growth 5Y-29.5%

1

2. Health

2.1 Basic Checks

VNTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for VNTR has been increased compared to 1 year ago.
Compared to 5 years ago, VNTR has more shares outstanding
Compared to 1 year ago, VNTR has a worse debt to assets ratio.

2.2 Solvency

VNTR has an Altman-Z score of 0.38. This is a bad value and indicates that VNTR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.38, VNTR is doing worse than 76.92% of the companies in the same industry.
VNTR has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
VNTR has a better Debt to Equity ratio (0.02) than 83.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z 0.38
ROIC/WACCN/A
WACC5.34%

2.3 Liquidity

VNTR has a Current Ratio of 0.74. This is a bad value and indicates that VNTR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of VNTR (0.74) is worse than 90.11% of its industry peers.
VNTR has a Quick Ratio of 0.74. This is a bad value and indicates that VNTR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.41, VNTR is not doing good in the industry: 91.21% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.41

0

3. Growth

3.1 Past

VNTR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -3300.00%.
The Revenue has decreased by -1.76% in the past year.
Measured over the past years, VNTR shows a decrease in Revenue. The Revenue has been decreasing by -0.33% on average per year.
EPS 1Y (TTM)-3300%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-300%
Revenue 1Y (TTM)-1.76%
Revenue growth 3Y0.67%
Revenue growth 5Y-0.33%
Revenue growth Q2Q-31.59%

3.2 Future

VNTR is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -2.60% yearly.
The Revenue is expected to decrease by -2.01% on average over the next years.
EPS Next Y-403.14%
EPS Next 2Y-41.02%
EPS Next 3Y-2.6%
EPS Next 5YN/A
Revenue Next Year-17.52%
Revenue Next 2Y-5.89%
Revenue Next 3Y-2.01%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for VNTR. In the last year negative earnings were reported.
Also next year VNTR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of VNTR indicates a somewhat cheap valuation: VNTR is cheaper than 61.54% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.62

4.3 Compensation for Growth

A cheap valuation may be justified as VNTR's earnings are expected to decrease with -2.60% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.02%
EPS Next 3Y-2.6%

0

5. Dividend

5.1 Amount

No dividends for VNTR!.
Industry RankSector Rank
Dividend Yield N/A

VENATOR MATERIALS PLC

NYSE:VNTR (5/12/2023, 7:06:13 PM)

After market: 0.2783 +0.01 (+3.57%)

0.2687

-0.02 (-7.66%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap29.03M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 3.91%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.74
Quick Ratio 0.41
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-3300%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-403.14%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.76%
Revenue growth 3Y0.67%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y